CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current protocols in stem cell biology

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cpsc.46PMID 29512106PMCID PMC5846340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

  2017cited by this paper
• Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

  2017cited by this paper
• Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins

  2017cited by this paper
• cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness

  2016cited by this paper
• Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR

  2016cited by this paper
• Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing

  2016influential reference
• Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.

  2015cited by this paper
• Comparison of T7E1 and Surveyor Mismatch Cleavage Assays to Detect Mutations Triggered by Engineered Nucleases

  2015cited by this paper
• Genome engineering using CRISPR-Cas9 system.

  2015cited by this paper
• CRISPR/Cas9-mediated endogenous protein tagging for RESOLFT super-resolution microscopy of living human cells

  2015cited by this paper
• Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells.

  2015influential reference
• A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells

  2015cited by this paper
• The Derivation of Primary Human Epicardium-Derived Cells.

  2015cited by this paper
• Genome editing in human stem cells.

  2014cited by this paper
• Stable Enhanced Green Fluorescent Protein Expression After Differentiation and Transplantation of Reporter Human Induced Pluripotent Stem Cells Generated by AAVS1 Transcription Activator‐Like Effector Nucleases

  2014cited by this paper
• CRISPR RNA-guided activation of endogenous human genes

  2013cited by this paper
• Optimization of scarless human stem cell genome editing

  2013cited by this paper
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• RNA-Guided Human Genome Engineering via Cas9

  2013influential reference
• Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

  2013cited by this paper
• Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells*

  2013cited by this paper
• RNA-programmed genome editing in human cells

  2013cited by this paper
• Genome engineering using the CRISPR-Cas9 system

  2013cited by this paper
• A Robust Strategy for Negative Selection of Cre-LoxP Recombination-Based Excision of Transgenes in Induced Pluripotent Stem Cells

  2013cited by this paper
• ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

  2013cited by this paper
• DNA targeting specificity of RNA-guided Cas9 nucleases

  2013cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages.

  2012cited by this paper
• Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

  2011cited by this paper
• High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice

  2011cited by this paper
• Short DNA sequences inserted for gene targeting can accidentally interfere with off‐target gene expression

  2010cited by this paper
• Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.

  2009cited by this paper
• Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors

  2009influential reference
• A Simple Cipher Governs DNA Recognition by TAL Effectors

  2009cited by this paper
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009cited by this paper
• Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases

  2009cited by this paper
• Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases

  2006cited by this paper
• Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer.

  2004cited by this paper

• XPRESSO: Rapid genetic engineering of human pluripotent stem cells for durable overexpression using a modular anti-silencing vector

  2025cites this paper
• Unveiling genomic rearrangements in engineered iPSC lines by optical genome mapping

  2025cites this paper
• Unveiling Genomic Rearrangements in Engineered iPSC Lines by Optical Genome Mapping

  2025cites this paper
• New Perspectives in Stem Cell Transplantation and Associated Therapies to Treat Retinal Diseases: From Gene Editing to 3D Bioprinting

  2024cites this paper
• Making gene editing accessible in resource limited environments: recommendations to guide a first-time user

  2024cites this paper
• Identification of a family with van der Hoeve’s syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs

  2024cites this paper
• AMD and Stem Cell-Based Therapies

  2023cites this paper
• Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

  2023cites this paper
• CGMP compliant microfluidic transfection of induced pluripotent stem cells for CRISPR-mediated genome editing.

  2023cites this paper
• Investigating The Correction of IVS II-1 (G> A) Mutation in HBB Gene in TLS-12 Cell Line Using CRISPR/Cas9 System

  2023cites this paper
• Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells

  2022cites this paper
• Characterization of CRISPR-Cas systems in Bifidobacterium breve

  2022cites this paper
• Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders

  2022cites this paper
• Highly Efficient CRISPR/Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells

  2022cites this paper
• CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals.

  2021cites this paper
• Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stemcells.

  2021cites this paper
• Transplantation of fat tissues and iPSC-derived energy expenditure adipocytes to counteract obesity-driven metabolic disorders: Current strategies and future perspectives

  2021cites this paper
• Microfluidic processing of stem cells for autologous cell replacement

  2021cites this paper
• CRISPR/Cas9 technologies to manipulate human induced pluripotent stem cells

  2021cites this paper
• Synthetic Biology and Tissue Engineering: Toward Fabrication of Complex and Smart Cellular Constructs

  2020cites this paper
• Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex

  2020cites this paper
• Hallmarks of Health.

  2020cites this paper
• Methods for renal lineage tracing: In vivo and beyond.

  2019cites this paper
• Cell and Gene Therapies for Mucopolysaccharidoses: Base Editing and Therapeutic Delivery to the CNS

  2019cites this paper
• Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.

  2019cites this paper
• Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9

  2019cites this paper
• The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus

  2019cites this paper
• Retinal therapy with induced pluripotent stem cells; leading the way to human clinical trials

  2019cites this paper
• Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations

  2019cites this paper
• A transient reporter for editing enrichment (TREE) in human cells

  2019cites this paper
• Functional Role of Circular RNA in Regenerative Medicine.

  2018cites this paper
• Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.

  2018cites this paper
• CRISPR‐Cas9 genome engineering: Treating inherited retinal degeneration

  2018cites this paper